Does and should breast cancer genetic counselling include lifestyle advice?, Familial Cancer, vol.13, pp.35-44, 2014. ,
The knowledge value-chain of genetic counseling for breast cancer: an empirical assessment of prediction and communication processes, Familial Cancer, vol.15, issue.1, pp.1-17, 2015. ,
Assessing women at high risk of breast cancer: a review of risk assessment models, J Natl Cancer Inst, vol.102, pp.680-691, 2010. ,
The BOADICEA model of genetic susceptibility to breast and ovarian cancer, Br J Cancer, vol.91, pp.1580-1590, 2004. ,
Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics, J Med Genet, vol.45, pp.425-431, 2008. ,
Use of the BOADICEA web application in clinical practice: appraisals by clinicians from various countries, Familial Cancer, vol.17, issue.1, pp.31-41, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02275380
Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort, Breast Cancer Res, vol.17, issue.1, p.147, 2015. ,
Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications, Breast Cancer Res Treat, vol.164, issue.2, pp.263-284, 2017. ,
Genetic analysis of breast cancer in the cancer and steroid hormone study, Am J Hum Genet, vol.48, pp.232-242, 1991. ,
Maximising response from GPs to questionnaire surveys: do length or incentives make a difference, BMC Med Res Methodol, vol.15, p.3, 2015. ,
Two decades after BRCA: setting paradigms in personalized cancer care and prevention, Science, vol.343, pp.1466-1470, 2014. ,
Clinical software development for the web: lessons learned from the BOADICEA project, BMC Med Inform Decis Mak, vol.12, p.30, 2012. ,
Impact of a panel of 88 single nucleotide polymorphisms on the risk of breast cancer in high-risk women: results from two randomized tamoxifen prevention trials, J Clin Oncol, vol.35, issue.7, pp.743-750, 2016. ,
International variation in female breast cancer incidence and mortality rates, Cancer Epidemiol Biomark Prev, vol.24, pp.1495-1506, 2015. ,
Gene-panel sequencing and the prediction of breast-cancer risk, N Engl J Med, vol.372, pp.2243-2257, 2015. ,
Methods to increase response to postal and electronic questionnaires, Cochrane Database Syst Rev, vol.8, issue.3, p.8, 2009. ,
A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO, J Med Genet, vol.41, pp.474-480, 2004. ,
Update on the Manchester scoring system for BRCA1 and BRCA2 testing, J Med Genet, vol.42, issue.7, p.39, 2005. ,
Breast cancer risk-assessment models, Breast Cancer Res, vol.9, issue.5, p.213, 2007. ,
Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals, J Clin Oncol, vol.20, pp.1480-1490, 2002. ,
Projecting individualized probabilities of developing breast cancer for white females who are being examined annually, J Natl Cancer Inst, vol.81, pp.1879-1886, 1989. ,
Can diet and lifestyle prevent breast cancer: what is the evidence?, Am Soc Clin Oncol Educ Book, vol.35, pp.66-73, 2015. ,
and the UK show variable breast cancer risk communication profiles, General practitioners and breast surgeons in, vol.15, p.243, 2002. ,
Refining breast cancer risk stratification: additional genes, additional information, Am Soc Clin Oncol Educ Book, vol.35, pp.44-56, 2016. ,
,
Breast cancer risk associated with estrogen exposure and truncating mutation location in BRCA1/2 carriers, Cancer Epidemiol Biomark Prev, vol.24, pp.698-707, 2015. ,
URL : https://hal.archives-ouvertes.fr/inserm-01990932
BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface, Br J Cancer, vol.110, pp.535-545, 2014. ,
Incorporating truncating variants in PALB2, CHEK2, and ATM into the BOADICEA breast cancer risk model, Genet Med, vol.18, pp.1190-1198, 2016. ,
LimeSurvey: an open source survey tool, 2015. ,
Prospective validation of the breast cancer risk prediction model BOADICEA and a batch-mode version BOADICEACentre, Br J Cancer, vol.109, pp.1296-1301, 2013. ,
Recent enhancements to the genetic risk prediction model BRCAPRO, Cancer Inform, vol.14, pp.147-157, 2015. ,
A systematic review of breast cancer incidence risk prediction models with meta-analysis of their performance, Breast Cancer Res Treat, vol.132, pp.365-377, 2012. ,
Decision making for breast cancer prevention among women at elevated risk, Breast Cancer Res, vol.19, p.34, 2017. ,
Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2, Am J Hum Genet, vol.62, pp.145-158, 1998. ,
Validity of models for predicting BRCA1 and BRCA2 mutations, Ann Intern Med, vol.147, pp.441-450, 2007. ,
Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance, Breast Cancer Res, vol.14, issue.6, p.144, 2012. ,
Assessing absolute changes in breast cancer risk due to modifiable risk factors, Breast Cancer Res Treat, vol.152, pp.193-197, 2015. ,
R: a language and environment for statistical computing, R Foundation for Statistical Computing, 2016. ,
BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing, JAMA, vol.278, pp.1242-1250, 1997. ,
Using multivariate statistics, 6th edn, 2013. ,
A breast cancer prediction model incorporating familial and personal risk factors, Stat Med, vol.23, p.1111, 2004. ,